Health Insurance Whistleblower shares how Americans are being misled about patient health careHealth Insurance Whistleblower shares how Americans are being misled about patient health care

Analysts say ‘Buy a dip’ from these 3 Stocks
Smart stock investing should not be emotional, but investors are just people, after all, which makes it difficult to follow a sensible trading strategy. Investors should keep in mind Warren Buffett's advice: “We just try to be fearful when others are selfish and greedy only when others are.” What Buffett recommends is the oldest advice on the market: buy low and sell high. With that in mind, we started our search for compulsory investment discounts. 

Using the TipRanks database, we were able to find 3 lower shares in their latest peaks, while some Wall Street analysts recommend ‘buying a dip.’ Let’s take a closer look. Teladoc Health (TDOC) We will start with Teladoc, a remote healthcare service, which uses online connections to connect patients and doctors with non-emergency services, including ear problems, laboratory transfusions, basic medical advice and diagnoses, and a doctor's prescription. 

In the company's words, "remote home telephony by primary care physicians," uses digital technology to provide an old-fashioned service.
The Teladoc service is in high demand, and in the year of the corona saw the company thrive - its business model was well suited to the conditions of the COVID-19 epidemic. Gross annual revenue by 2020 has grown by 98% annually, to 1.09 billion, and total patient visits have increased by 156%, to 10.6 million. In addition, the company in October concluded its merger with rival Livongo, in a $ 18.5 billion deal. 

Teladoc shareholders now control 58% of the combined company. While the move added to Teladoc's capabilities and therefore the potential patient base, it also meant the corporate made an enormous expense during Q4. Teladoc had to pay in cash for the merger, and as a result, Q4 acquisition results showed a significant EPS loss of $ 3.07 per share. 

In addition to the Q4 net loss, investors are also worried about the 2021 membership direction. Specifically, this figure is likely to be between 52 million and 54 million, meaning an increase of + 3.4-7.4% year on year. This has dropped dramatically from 40% by 2020 and + 61% in 2019.
Stocks have dropped by 37% since they first rose in mid-February, but Canaccord five-star analyst Richard Close says 'buy this dip.' “Prominent areas such as multi-product sales, increased consumption, new registration capacity, and growing tourism in non-communicable areas affect membership metrics where everything is said and done. 

Opportunities have already been shown to enter (or accumulate shares) in Teladoc - we believe this is one of the opportunities, ”said Vala confidently. 

Close this comment with the purchase price and the $ 330 price tag which means a 78% increase over the next 12 months. (To view the Close track record, click here) Overall, Teladoc has generated a huge Wall Street interest. There are 21 reviews in stock, 13 of which are to be purchased and 8 to hold, giving TDOC a Moderate Buy consensus rating.


The stock sells for $ 185.43, and its price target of $ 255.05 suggests a one-year increase of ~ 38%. (See TDOC stock analysis on TipRanks) Agnico Eagle Mines (AEM) From medical care we will move on to the mining industry, because sometimes having a gold mine is the next thing to have gold. Agnico Eagle has been a Canadian gold miner in business for more than 60 years. 

The company has active mining operations in Canada, Mexico and Finland, and has shown strong production by 2020. The company’s Q4 report has details of more than 501,000 gold ounces produced, with a production price of $ 771 per ounce - against ‘a total funding cost of $ 985 per hour. That quarterly performance is doubled in the full 2020 year.


Total gold production came in at more than 1.73 million ounces, the highest end of the previously published index, and the cost of one-hour production, $ 838, was much lower than the annual subsidy cost of $ 1,051 per hour. Higher productivity - the fourth quarter’s number was the company’s record - led to higher revenue. Agnico reported a total Q4 salary of $ 205.2 million, which went up to 85 cents per share. For the full year, revenue amounted to $ 511.6 million, or $ 2.12 per share. 

This figure accounted for a 9 per cent share loss in Q1, and was 6% higher than the 2019 figure. Despite strong figures for the last year of 2020, AEM shares have declined since the release of revenue, declining another 21% of their value.
While the company is profitable, and the product meets expectations, earnings in Q4 decreased by 7.6% respectively and 38% annually. To cover this CIBC stock, analyst Anita Soni writes, "In our view, the market reaction after quarterly revenue has passed and that we would recommend that investors increase the dip position ... biological, testing technologies (evident in the dynamic replenishment of dynamic and additional resources in the relevant year of COVID), project pipeline, and strict management. ”According to the comment, Soni has set a tag of $ 104 to match the Outperform (ie Buy) rate. 

This is a one-year high rate of 73% off current levels. (To view Soni's track record, click here) Overall, Agnico Eagle receives a Strong Buy analyst's consensus rating, based on 12 recent updates including 9 purchases. against 3 Holds.


The shares are valued at - $ 60.12 and its $ 85.62 target price means 42% higher power next year. (See AEM stock analysis on TipRanks) Redfin (RDFN) Lastly Redfin, Seattle-based, online real estate broker, with a low-cost business model (1% to 3% ) so that sellers can register their homes and close the sale. The company aims to make home visits, listing the first and most convenient and easy entry procedures